Cel-Sci Corp Series S
CVM.WS
CVM.WS was delisted on the 8th of October, 2018.
6 hedge funds and large institutions have $66K invested in Cel-Sci Corp Series S in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
14% less funds holding
Funds holding: 7 → 6 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
66% less capital inflows, than outflows
Capital inflows: $1.69K | Capital outflows: $5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.09K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$608 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| 2 |
Virtu Financial
New York
|
-$2K |
| 3 |
Two Sigma Securities
New York
|
-$1K |
CVM.WS Hedge Fund Activity: Q4 2017 in Review
6 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in Cel-Sci Corp Series S (CVM.WS) for Q4 2017, worth a combined $66K — down 33% from $98K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CVM.WS and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Ameriprise, opening a new position worth an estimated $1.09K. The largest seller was UBS Group, exiting entirely with an estimated $2K sold.
- 6 institutional investors held Cel-Sci Corp Series S (CVM.WS) as of Q4 2017, down from 7 in Q3 2017.
- Funds reported $66K of Cel-Sci Corp Series S stock for Q4 2017, down 33% quarter-over-quarter.
- 2 funds opened new Cel-Sci Corp Series S positions in Q4 2017 and 3 closed out, a net change of -1 holder.
- The largest Cel-Sci Corp Series S buyer in Q4 2017 was Ameriprise, an estimated $1.09K added.
- The largest Cel-Sci Corp Series S seller in Q4 2017 was UBS Group, an estimated $2K sold.
Based on aggregated 13F filings for Q4 2017.